<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="139551">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01284283</url>
  </required_header>
  <id_info>
    <org_study_id>STAR 2 Year</org_study_id>
    <nct_id>NCT01284283</nct_id>
  </id_info>
  <brief_title>2-Year Post-Approval Study to Investigate the Scandinavian Total Ankle Replacement System (STAR) Ankle Under Actual Conditions of Use</brief_title>
  <acronym>STAR</acronym>
  <official_title>2-Year Post-Approval Study to Investigate the STAR Ankle Under Actual Conditions of Use</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Stryker Trauma GmbH</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Stryker Trauma GmbH</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This post-approval study is being conducted to examine the performance of the STAR Ankle
      under actual conditions of use.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This investigation is a prospective, multi-center, single-arm study. 98 subjects are to be
      enrolled in this clinical investigation. Enrolled subjects will be assessed at
      Pre-Operative, Operative/Discharge, and at 6 Weeks, 6, 12, and 24 Months after the index
      procedure. Safety, efficacy, and effectiveness analyses will be performed for all follow-up
      points during the study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Primary Endpoint</measure>
    <time_frame>2 years</time_frame>
    <description>The primary objective of this study is to examine the performance of the STAR™ Ankle under actual conditions of use, employing the approved instructions for use, labeling, and instrumentation. The principal endpoint consists of evaluating the safety and effectiveness of the STAR™ Ankle. Overall patient success is defined as:
≥ 40 point improvement in total Buechel-Pappas Scale score
No device failures
Radiographic success (no clinically significant radiographic evidence of loosening, tilting or migration &gt; 4mm)
No major complications</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Secondary Endpoints</measure>
    <time_frame>2 years</time_frame>
    <description>In addition to the principal endpoint, information on the following efficacy outcomes will be assessed:
Total Buechel-Pappas Scale score
Pain Visual Analog Scale
Quality of Life
American Orthopaedic Foot &amp; Ankle Society (AOFAS) Ankle Hindfoot Scale
The following radiographic endpoints will be assessed by anterior/posterior and lateral radiographs by the treating surgeon and an independent radiographic reviewer:
Radiolucency
Migration</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">98</enrollment>
  <condition>Primary Arthrosis</condition>
  <condition>Post Traumatic Arthritis</condition>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Single</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Device: Scandinavian Total Ankle Replacement System (STAR Ankle)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Scandinavian Total Ankle Replacement System (STAR Ankle)</intervention_name>
    <description>For total ankle replacement</description>
    <arm_group_label>Single</arm_group_label>
    <other_name>STAR</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Moderate or severe pain, loss of mobility and function of the ankle (Buechel-Pappas
             Scale)

          -  Primary arthrosis, post traumatic arthrosis or rheumatoid arthrosis

          -  At least six months of conservative treatment for severe ankle conditions, confirmed
             by the patient medical history, radiograph studies and medication record

          -  Willing and able to give informed consent

        Exclusion Criteria:

          -  Patients who have not reached skeletal maturity

          -  Active or prior deep infection inthe ankle joint or adjacent bones

          -  Prior arthrodesis at the involved site

          -  History of prior mental illness or patient demonstrates that their mental capacity
             may interfere with their ability to follow the study protocol

          -  Obesity (weight greater than 250 lbs)

          -  History of current prior drug abuse or alcoholism

          -  Any physical condition precluding major surgery

          -  Hindfoot malpositioned by more than 35 degrees or forefoot malalignment which would
             preclude a plantigrade foot

          -  Lower extremity vascular insufficiency demonstrated by Doppler arterial pressure

          -  Avascular necrosis of the talus

          -  Inadequate skin coverage above the ankle joint

          -  Patients under the age of 35 who are unwilling or unable to accept the physical
             limitations imposed by ankle arthroplasty, including limitations on certain vigorous
             physical activities (e.g. basketball, football) and on manual labor

          -  Juvenile onset Type I diabetes

          -  Adult onset Type II diabetes when accompanied by neuropathic changes or a history of
             foot infection in either foot

          -  Pregnancy

          -  Avascular necrosis of the tibia

          -  Significant bone tumor of the foot or ankle

          -  Severe deformity that would not normally be eligible for ankle surgery

          -  Prior surgery and/or injury that has adversely affected the ankle bone stock

          -  Severe osteoporotic or osteopenic condition or other conditions that may lead to
             inadequate implant fixation in the bone

          -  Insufficient ligament support

          -  Motor dysfunction due to neuromuscular impairment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Rebecca Gibson</last_name>
    <email>rebecca.gibson@stryker.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Kaiser Permanente</name>
      <address>
        <city>San Francisco</city>
        <state>California</state>
        <zip>94118</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eva Greenstein</last_name>
      <email>Eva.R.Greenstein@kp.org</email>
    </contact>
    <contact_backup>
      <last_name>Alfonso Gutierrez</last_name>
      <email>alfonso.r.ramirez-gutierrez@kp.org</email>
    </contact_backup>
    <investigator>
      <last_name>John M Schuberth, DPM</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christy King, DPM</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>William Beaumont Hospital</name>
      <address>
        <city>Royal Oak</city>
        <state>Michigan</state>
        <zip>48085</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kristy McCandlish</last_name>
      <email>kmccandlish@beaumont.edu</email>
    </contact>
    <investigator>
      <last_name>Allen Grant, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kenneth Mroczek, MD-NYU</name>
      <address>
        <city>New York City</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ariel Aponte</last_name>
      <email>Ariel.Aponte@nyumc.org</email>
    </contact>
    <investigator>
      <last_name>Kenneth Mroczek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cary Chapman, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Steven Sheskier, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University of Pennsylvania Health Systems-PA Foot and Ankle Surgeons</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19106</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Kim Lacy</last_name>
      <email>Kim.Lacy@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Keith L Wapner, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Farber, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wen Chao, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Center for Foot and Ankle Restoration</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Active, not recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2016</verification_date>
  <lastchanged_date>September 30, 2016</lastchanged_date>
  <firstreceived_date>November 2, 2010</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Arthrosis</keyword>
  <keyword>Rheumatoid Arthrosis</keyword>
  <keyword>Arthritic joint</keyword>
  <keyword>Rheumatoid Arthritis</keyword>
  <keyword>Osteoarthritis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
    <mesh_term>Joint Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
